These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 24599400

  • 1. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
    Xu YH, Xu K, Sun Y, Liou B, Quinn B, Li RH, Xue L, Zhang W, Setchell KD, Witte D, Grabowski GA.
    Hum Mol Genet; 2014 Aug 01; 23(15):3943-57. PubMed ID: 24599400
    [Abstract] [Full Text] [Related]

  • 2. Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.
    Xu YH, Sun Y, Ran H, Quinn B, Witte D, Grabowski GA.
    Mol Genet Metab; 2011 Apr 01; 102(4):436-47. PubMed ID: 21257328
    [Abstract] [Full Text] [Related]

  • 3. Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model.
    Dasgupta N, Xu YH, Li R, Peng Y, Pandey MK, Tinch SL, Liou B, Inskeep V, Zhang W, Setchell KD, Keddache M, Grabowski GA, Sun Y.
    Hum Mol Genet; 2015 Dec 15; 24(24):7031-48. PubMed ID: 26420838
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
    Rocha EM, Smith GA, Park E, Cao H, Graham AR, Brown E, McLean JR, Hayes MA, Beagan J, Izen SC, Perez-Torres E, Hallett PJ, Isacson O.
    Antioxid Redox Signal; 2015 Aug 20; 23(6):550-64. PubMed ID: 26094487
    [Abstract] [Full Text] [Related]

  • 6. Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease.
    Blumenreich S, Yaacobi C, Vardi A, Barav OB, Vitner EB, Park H, Wang B, Cheng SH, Sardi SP, Futerman AH.
    J Neurochem; 2021 Mar 20; 156(5):692-701. PubMed ID: 32743826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice.
    Liou B, Peng Y, Li R, Inskeep V, Zhang W, Quinn B, Dasgupta N, Blackwood R, Setchell KD, Fleming S, Grabowski GA, Marshall J, Sun Y.
    Hum Mol Genet; 2016 Dec 01; 25(23):5126-5141. PubMed ID: 27655403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.
    Gegg ME, Verona G, Schapira AHV.
    Hum Mol Genet; 2020 Jun 27; 29(10):1716-1728. PubMed ID: 32391886
    [Abstract] [Full Text] [Related]

  • 14. Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.
    Yap TL, Gruschus JM, Velayati A, Westbroek W, Goldin E, Moaven N, Sidransky E, Lee JC.
    J Biol Chem; 2011 Aug 12; 286(32):28080-8. PubMed ID: 21653695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. iPSC-derived neural precursor cells engineering GBA1 recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathology.
    Peng Y, Liou B, Lin Y, Mayhew CN, Fleming SM, Sun Y.
    Mol Ther Methods Clin Dev; 2023 Jun 08; 29():185-201. PubMed ID: 37063480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
    Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH.
    Ann Neurol; 2012 Sep 08; 72(3):455-63. PubMed ID: 23034917
    [Abstract] [Full Text] [Related]

  • 20. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
    Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D.
    Cell; 2011 Jul 08; 146(1):37-52. PubMed ID: 21700325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.